Learn

Upper GI Cancer Research Review Issue 12 with commentary by Dr Pei Ding, a medical oncologist at Nepean and Westmead hospitals.

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in upper GI cancer. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

Details

• SANO: active surveillance for oesophageal cancer with a clinical CR after neoadjuvant chemoradiotherapy
• Adjuvant chemotherapy after localised pancreatic adenocarcinoma resection & pre-operative (m)FOLFIRINOX
• Improved OS with PERT in advanced pancreatic ductal adenocarcinoma
• ESPAC4: long-term OS with adjuvant gemcitabine + capecitabine in pancreatic adenocarcinoma
• Perioperative chemotherapy vs. surgery in resectable dMMR/MSI-H gastric cancer
• Larotrectinib in TRK fusion GI cancer
• Adjuvant chemotherapy vs. observation in resected biliary tract cancers
• Determinants of response/resistance in HER2-positive gastric cancer
• Adjuvant chemotherapy vs. observation in resected intrahepatic cholangiocarcinoma
• Follow-up in elderly stage I gastric cancer after curative gastrectomy

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.